PERSPECTIVE THERAPEUTICS INC (CATX)

US46489V3024 - Common Stock

12.29  -0.37 (-2.92%)

After market: 12.29 0 (0%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to CATX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 22.95. This target is 86.74% above the current price.
CATX was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CATX.
In the previous month the buy percentage consensus was at a similar level.
CATX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 12.2917.1723.4622.9528.35 - 39.71% 90.89% 86.74% 130.68%
Up and Down Grades
Date Firm Action Rating
2024-10-11 Oppenheimer Reiterate Outperform -> Outperform
2024-10-01 Wedbush Initiate Outperform
2024-09-25 Truist Securities Initiate Buy
2024-09-10 Cantor Fitzgerald Reiterate Overweight
2024-09-09 Cantor Fitzgerald Reiterate Overweight
2024-09-06 Cantor Fitzgerald Reiterate Overweight
2024-09-03 Cantor Fitzgerald Reiterate Overweight
2024-08-16 RBC Capital Maintains Outperform -> Outperform
2024-08-13 Oppenheimer Maintains Outperform -> Outperform
2024-07-25 B of A Securities Initiate Buy
2024-06-25 Cantor Fitzgerald Reiterate Overweight
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-06-18 Cantor Fitzgerald Reiterate Overweight
2024-06-18 Oppenheimer Reiterate Outperform -> Outperform
2024-06-14 RBC Capital Reiterate Outperform -> Outperform
2024-05-16 Jones Trading Maintains Buy -> Buy
2024-05-14 RBC Capital Initiate Outperform
2024-05-09 Cantor Fitzgerald Initiate Overweight
2024-04-09 B. Riley Securities Maintains Buy -> Buy
2024-04-01 Oppenheimer Reiterate Outperform -> Outperform
2024-03-19 Oppenheimer Reiterate Outperform -> Outperform
2024-01-26 B. Riley Securities Initiate Buy
2023-11-15 JonesTrading Initiate Buy
2023-05-19 Oppenheimer Maintains Outperform